Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-21

FDA Approved: ZTALMY — Supplemental Application (Immedica Pharma US Inc)

View source ↗

Summary

FDA approved a supplemental application for ZTALMY (ganaxolone) submitted by Immedica Pharma US Inc. The approval updates the product label as described in the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZTALMY (ganaxolone)

Snippet

SUPPL AP for ZTALMY (GANAXOLONE)